Tammy L. Kindel M.D., Ph.D., Girish P. Joshi M.D., Teresa LaMasters M.D.
{"title":"对温和等的反应。“致编辑关于多学会临床实践指南-围手术期安全使用胰高血糖素样肽-1受体激动剂的信”。","authors":"Tammy L. Kindel M.D., Ph.D., Girish P. Joshi M.D., Teresa LaMasters M.D.","doi":"10.1016/j.soard.2025.01.012","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":49462,"journal":{"name":"Surgery for Obesity and Related Diseases","volume":"21 6","pages":"Page 696"},"PeriodicalIF":3.8000,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Response to Milder et al. “Letter to the editor regarding multisociety clinical practice guidance- safe use of glucagon-like peptide-1 receptor agonists in perioperative period”\",\"authors\":\"Tammy L. Kindel M.D., Ph.D., Girish P. Joshi M.D., Teresa LaMasters M.D.\",\"doi\":\"10.1016/j.soard.2025.01.012\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":49462,\"journal\":{\"name\":\"Surgery for Obesity and Related Diseases\",\"volume\":\"21 6\",\"pages\":\"Page 696\"},\"PeriodicalIF\":3.8000,\"publicationDate\":\"2025-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Surgery for Obesity and Related Diseases\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S155072892500070X\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/2/14 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q1\",\"JCRName\":\"SURGERY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Surgery for Obesity and Related Diseases","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S155072892500070X","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/2/14 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"SURGERY","Score":null,"Total":0}
Response to Milder et al. “Letter to the editor regarding multisociety clinical practice guidance- safe use of glucagon-like peptide-1 receptor agonists in perioperative period”
期刊介绍:
Surgery for Obesity and Related Diseases (SOARD), The Official Journal of the American Society for Metabolic and Bariatric Surgery (ASMBS) and the Brazilian Society for Bariatric Surgery, is an international journal devoted to the publication of peer-reviewed manuscripts of the highest quality with objective data regarding techniques for the treatment of severe obesity. Articles document the effects of surgically induced weight loss on obesity physiological, psychiatric and social co-morbidities.